Vertex Pharmaceuticals Inc. buy EPG2026
Start price
27.01.13
/
50%
€34.73
Target price
19.04.13
€40.00
Performance (%)
85.13%
End price
19.04.13
€64.30
Summary
This prediction ended on 19.04.13 with a price of €64.30. The BUY prediction by EPG2026 for Vertex Pharmaceuticals Inc. saw massive gains of 85.13%. EPG2026 has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Vertex Pharmaceuticals Inc. | -0.344% | -0.344% | 38.714% | 145.986% |
iShares Core DAX® | -0.552% | 3.405% | 17.621% | 18.214% |
iShares Nasdaq 100 | -1.415% | 4.613% | 28.506% | 54.410% |
iShares Nikkei 225® | -0.877% | -1.396% | 9.284% | 4.292% |
iShares S&P 500 | -0.415% | 3.338% | 25.914% | 47.401% |
Comments by EPG2026 for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Sehr gute Biotechaktie
Vertex Pharma hat gute Produkte in der Pipeline
(Vom Mitglied beendet)